Curaleaf (OTCMKTS:CURLF) Shares Gap Down - Should You Sell?

Key Points

• Curaleaf shares gapped down pre-market, opening at $2.31 after a prior close of $2.418 and last trading at $2.35 on volume of 111,719 shares.
• Analyst sentiment is broadly positive with an average rating of Buy (two Strong Buy, one Buy, one Hold); Zacks upgraded to Hold from Strong Sell and Alliance Global Partners reiterated a Buy.
• The company remains unprofitable despite beating last quarter's EPS ($-0.05 vs. est. $-0.08) and revenue ($333.07M vs. est. $328.7M); market cap is $1.64B, P/E is negative, margins and ROE are negative, and analysts expect -$0.25 EPS for the year.

Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report) shares gapped down prior to trading on Monday . The stock had previously closed at $2.4180, but opened at $2.31. Curaleaf shares last traded at $2.35, with a volume of 111,719 shares changing hands.

Analyst Ratings Changes

CURLF has been the subject of several recent analyst reports. Zacks Research raised shares of Curaleaf from a "strong sell" rating to a "hold" rating in a research report on Thursday, January 1st. Alliance Global Partners restated a "buy" rating on shares of Curaleaf in a research note on Monday, December 22nd. Two research analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has assigned a Hold rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Buy".

Curaleaf Price Performance

The stock has a market capitalization of $1.64 billion, a P/E ratio of -8.01 and a beta of 0.77. The business has a fifty day simple moving average of $2.31 and a 200 day simple moving average of $2.59. The company has a current ratio of 1.52, a quick ratio of 0.76 and a debt-to-equity ratio of 1.14.

Curaleaf (OTCMKTS:CURLF - Get Free Report) last announced its quarterly earnings results on Thursday, February 26th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.08) by $0.03. Curaleaf had a negative return on equity of 23.17% and a negative net margin of 18.08%.The business had revenue of $333.07 million during the quarter, compared to the consensus estimate of $328.70 million. On average, analysts expect that Curaleaf Holdings, Inc. will post -0.25 earnings per share for the current year.

Curaleaf Company Profile

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company's vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf's product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.